Influence of chelation and oxidation state on vanadium bioavailability, and their effects on tissue concentrations of zinc, copper, and iron

被引:52
作者
Thompson, KH
Tsukada, Y
Xu, ZM
Battell, M
McNeill, JH
Orvig, C
机构
[1] Univ British Columbia, Dept Chem, Med Inorgan Chem Grp, Vancouver, BC V6T 1Z1, Canada
[2] Univ British Columbia, Food Nutr & Hlth Program, Vancouver, BC V6T 1Z1, Canada
[3] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V6T 1Z1, Canada
基金
英国医学研究理事会; 加拿大健康研究院;
关键词
vanadium; zinc; bone; kidney; skeletal muscle; Caco-2; cells;
D O I
10.1385/BTER:86:1:31
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Today, vanadium compounds are frequently included in nutritional supplements and are also being developed for therapeutic use in diabetes mellitus. Previously, tissue uptake of vanadium from bis(maltolato)oxovanadium(IV) (BMOV) was shown to be increased compared to its uptake from vanadyl sulfate (VS). Our primary objective was to test the hypothesis that complexation increases vanadium uptake and that this effect is independent of oxidation state. A secondary objective was to compare the effects of vanadium complexation and oxidation state on tissue iron, copper, and zinc. Wistar rats were fed either ammonium metavanadate (AMV), VS, or BMOV (1.2 mM each in the drinking water). Tissue uptake of V following 12 wk of BMOV or AMV was higher than that from VS (p < 0.05). BMOV led to decreased tissue Zn and increased bone Fe content. The same three compounds were compared in a cellular model of absorption (Caco-2 cells). Vanadium uptake from VS was higher than that from BMOV or AMV at 10 min, but from BMOV (250 mu M only, 60 min), uptake was far greater than from AMV or VS. These results show that neither complexation nor oxidation state alone are adequate predictors of relative absorption, tissue accumulation, or trace element interactions.
引用
收藏
页码:31 / 44
页数:14
相关论文
共 48 条
[21]  
Nielsen F. H., 1997, FASEB Journal, V11, pA148
[22]  
Nielsen FH, 1998, J TRACE ELEM EXP MED, V11, P251, DOI 10.1002/(SICI)1520-670X(1998)11:2/3&lt
[23]  
251::AID-JTRA15&gt
[24]  
3.0.CO
[25]  
2-Q
[26]   INTERACTIONS AMONG VANADIUM, IRON, AND CYSTINE IN RATS - GROWTH, BLOOD PARAMETERS, AND ORGAN WT-BODY WT-RATIOS [J].
NIELSEN, FH ;
UHRICH, K ;
UTHUS, EO .
BIOLOGICAL TRACE ELEMENT RESEARCH, 1984, 6 (02) :117-132
[27]  
PARKER RDR, 1978, J ENVIRON PATHOL TOX, V2, P235
[28]   ORAL VANADYL SULFATE IN TREATMENT OF DIABETES-MELLITUS IN RATS [J].
RAMANADHAM, S ;
MONGOLD, JJ ;
BROWNSEY, RW ;
CROS, GH ;
MCNEILL, JH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (03) :H904-H911
[29]   Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats [J].
Reul, BA ;
Amin, SS ;
Buchet, JP ;
Ongemba, LN ;
Crans, DC ;
Brichard, SM .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (02) :467-477
[30]   The cellular uptake kinetics and acute biological effects of various oxovanadium species: A comparative study [J].
Reuland, DJ ;
Cao, ZX ;
Rosenhein, L ;
Poehlein, S ;
McCoy, L ;
Turner, J ;
Durham, T ;
Ganguli, S .
HORMONE AND METABOLIC RESEARCH, 1998, 30 (01) :29-33